AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
255.48
-2.67 (-1.03%)
At close: Aug 28, 2026, 4:00 PM EDT
255.53
+0.05 (0.02%)
After-hours: Aug 28, 2026, 7:59 PM EDT
AbbVie Market Cap
AbbVie has a market cap or net worth of $451.46 billion as of August 28, 2026. Its market cap has increased by 22.83% in one year.
Market Cap
451.46B
Enterprise Value
515.78B
1-Year Change
22.83%
Ranking
Category
Stock Price
$255.48
ChartMarket Cap Chart
Since January 2, 2013, AbbVie's market cap has increased from $55.49B to $451.46B, an increase of 713.60%. That is a compound annual growth rate of 16.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 451.46B | 11.80% |
| Dec 31, 2025 | 403.83B | 28.60% |
| Dec 31, 2024 | 314.02B | 14.77% |
| Dec 29, 2023 | 273.61B | -4.27% |
| Dec 30, 2022 | 285.80B | 19.40% |
| Dec 31, 2021 | 239.37B | 26.54% |
| Dec 31, 2020 | 189.17B | 44.48% |
| Dec 31, 2019 | 130.93B | -5.58% |
| Dec 31, 2018 | 138.67B | -10.18% |
| Dec 29, 2017 | 154.39B | 51.71% |
| Dec 30, 2016 | 101.76B | 5.08% |
| Dec 31, 2015 | 96.84B | -7.12% |
| Dec 31, 2014 | 104.26B | 24.10% |
| Dec 31, 2013 | 84.01B | 51.40% |
| Jan 2, 2013 | 55.49B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 1.05T |
| Johnson & Johnson | 645.95B |
| Merck & Co. | 366.00B |
| Novartis AG | 291.11B |
| AstraZeneca | 251.73B |
| Amgen | 233.78B |
| Novo Nordisk | 202.91B |
| Gilead Sciences | 180.64B |